Historical Stock Data
|52 Week High|
|52 Week Low|
How Will Tandem's Q3 Operational Performance Stack Up?
Oct 18, 2018 | 3:57 pm 1 Article Series
The cost of goods sold incurred by Tandem Diabetes Care (TNDM) is expected to increase in line with revenues by 55.66% from $14.4 million in the third quarter of fiscal 2017 to $22.41 million in the third quarter of fiscal 2018.